Cytokine profiles in Wegener's granulomatosis: Predominance of type 1 (Th1) in the granulomatous inflammation

Arthritis and Rheumatism

Volumn 42, Issue 4, 1999, Pages 742-750

  Csernok, Elena ^a,c   Trabandt, Andreas ^a   Müller, Antje ^a   Wang, Guchoan C ^a   Moosig, Frank ^a   Paulsen, Jens ^b   Schnabel, Armin ^a   Gross, Wolfgang L ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c Rheumaklinik Bad Bramstedt   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LUNG LAVAGE; MALE; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WEGENER GRANULOMATOSIS;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CLONE CELLS; DNA PROBES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-4; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TH1 CELLS; TH2 CELLS; TRANSCRIPTION, GENETIC; WEGENER GRANULOMATOSIS;

EID: 0032907826     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I     Document Type: Article

References (36)

1. Jennette CJ, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
2. Jenne DE, Tschopp J, Lüdemann J, Utech B, Gross WL. Wegener's autoantigen decoded. Nature 1990;346:520.
3. Gross WL, Csernok E. Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheumatol 1995;7:11-9.
4. Leavitt RY, Fauci AS. Pulmonary vasculitis. Am Rev Respir Dis 1986;134:149-66.
5. Fienberg R. The protracted superficial phenomenon in pathergic granulomatosis. Hum Pathol 1981;12:458-67.
6. Mark EJ, Matsubara O, Tan-Liu NS, Fienberg R. The pulmonary biopsy in the early diagnosis of Wegener's (pathergic) granulomatosis: a study based on 35 open lung biopsies. Hum Pathol 1988;19:1065-71.
7. Wegener F. Wegener's granulomatosis. Eur Arch Otorhinolaryngol 1990;247:133-42.
8. Nossal GJV. Host immunobiology and vaccine development. Lancet 1997;350:1316-9.
9. Wynn TA, Cheever AW. Cytokine regulation of granuloma formation in schistosomiasis. Curr Opin Immunol 1995;7:505-11.
10. Libraty DH, Airan LE, Uyemura K, Jullien D, Spellberg B, Rea TH, et al. Interferon-γ differentially regulates interleukin-10 production in leprosy. J Clin Invest 1997;99:336-41.
11. Carter LL, Dutton RW. Type 1 and type 2: a fundamental dichotomy for all T cell subsets. Curr Opin Immunol 1996;8:336-42.
12. Wang G, Hansen H, Tatsis E, Csernok E, Gross WL. High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis. Am J Med 1997;102:517-23.
13. Csernok E, Szymkowiak C, Wang G, Paulsen J, Gross WL. T cells cytokine profiles in patients with Wegener's granulomatosis [abstract]. Arthritis Rheum 1995;38 Suppl 9:S375.
14. Ludviksson BR, Sneller MC, Chua KS, Talar-Williams C, Langford CA, Ehrhardt RO, et al. Active Wegener's granulomatosis is associated with HLA-DR+ CD4-+ T-cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol 1998;160:3602-9.
15. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
16. Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A, et al. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum 1994;37:919-24.
17. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
18. Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. QJM 1993;86:447-58.
19. Ernst M, Kern P, Flad HD, Ulmer AJ. Effects of systemic (in vivo) interleukin-2 (IL-2) reconstitution in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) on phenotypes and functions of peripheral blood mononuclear cells (PBMC). J Clin Immunol 1986;6:170-81.
20. Schnabel A, Renz H, Csernok E, Wang G, Gross WL. Pulmonary T-cell subsets and T-cell receptor Vp repertoire in Wegener's granulomatosis [abstract]. Am J Respir Crit Care Med 1997;155: A984.
21. Schlesien M, Kaspar T, Gutfleisch J, Wolff-Vorbeck G, Peter HH. Activated CD4+ and CD8+ T cell subsets in Wegener's granulomatosis. Rheumatol Int 1995;14:213-9.
22. Schmitt WH, Heesen C, Csernok E, Rautmann A, Gross WL. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis: association with disease activity. Arthritis Rheum 1992;35:1088-96.
23. Nölle B, Specks U, Lüdemann J, Rohrbach MS, DeRemee RA, Gross WL. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 1989;111: 28-40.
24. Gross WL. Wegener's granulomatosis: new aspects of the disease course, immunodiagnostic procedures, and stage-adapted treatment. Sarcoidosis 1989;6:15-29.
25. Boudes P. Purely granulomatous Wegener's granulomatosis: a new concept for an old disease. Semin Arthritis Rheum 1990;19:365-70.
26. Ballieux BE, van der Burg SH, van der Woude F. Cell-mediated autoimmunity in patients with Wegener's granulomatosis. Clin Exp Immunol 1995;100:186-93.
27. Steinman L. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc Natl Acad Sci U S A 1996;93:2253-6.
28. Möller GM, de Jong TAW, van der Kwast TH, Overbeek SE, Wierenga-Wolf AF, Thepen T, et al. Immunolocalization of interleukin-4 in eosinophils in the bronchial mucosa of atopic asthmatics. Am J Respir Cell Mol Biol 1996;14:439-43.
29. Medina F, Camargo A, Moreno J, Zonana-Nacach A, Aceves-Avila J, Fraga A. Anti-neutrophil cytoplasmic autoantibodies in leprosy. Br J Rheumatol 1998;37:270-3.
30. Gallin MY, Jacobi AB, Büttner DW, Schönberger Ö, Marti T, Erttmann KD. Human autoantibody to defensin: disease association with hyperreactive onchocerciasis (Sowda). J Exp Med 1995; 182:41-7.
31. Cooper PJ. Autoimmunity and onchocerciasis. Lancet 1996;347:404.
32. Lüder CGK, Schulz-Key H, Banla M, Pritze S, Soboslay PT. Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease. Clin Exp Immunol 1996;105:245-53.
33. Burnham G. Ochocerciasis. Lancet 1998;351:1341-6.
34. Romagnani P, Annunziato F, Baccari MC, Parronchi P. T cells and cytokines in Crohn's disease. Curr Opin Immunol 1997;9:793-9.
35. Giacomelli R, Passacantando A, Parazanese I, Vernia P, Klidara N, Cucinelli N, et al. Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease. Clin Exp Immunol 1998;111:532-5.
36. Mathieson PW, Oliveira DBG. The role of cellular immunity in systemic vasculitis. Clin Exp Immunol 1995;100:183-5.